EUPRAXIA PHARMACEUTICALS INC. Accumulated Other Comprehensive Income
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Accumulated Other Comprehensive Income of -$2.04 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-03-13
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.04M.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.16M.
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.71M.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.79M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | -$2.04M 40-F · filed 2026-03-13 |
| 2024-12-31 | -$4.16M 40-F · filed 2026-03-13 |
| 2023-12-31 | -$2.71M 40-F · filed 2025-03-20 |
| 2022-12-31 | -$2.79M 40-F · filed 2024-04-01 |